UROTHELIAL CARCINOMA
Clinical trials for UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced bladder cancer patients in pfizer drug trial
Disease control Not yet recruitingThis study is testing a new medicine, PF-08634404, for adults with advanced bladder cancer that has spread. It will see if the drug is safe, how well it works to control the cancer, and how the body processes it. One group will get the new drug alone, and another group will get i…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New bladder wash could spare patients from major surgery
Disease control Not yet recruitingThis study is testing whether washing the bladder with two chemotherapy drugs, gemcitabine and docetaxel, can control high-risk bladder cancer that has stopped responding to the standard BCG treatment. The goal is to see if this approach can effectively treat the cancer and preve…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope to keep advanced bladder cancer at bay after chemotherapy
Disease control Not yet recruitingThis study is testing if a drug called avelumab can help control advanced bladder cancer for longer after patients finish a second round of chemotherapy. It will compare avelumab against standard supportive care in about 144 patients whose cancer has not gotten worse on their cur…
Matched conditions: UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Massive 3,000-Patient study to track real bladder cancer treatment outcomes
Knowledge-focused Not yet recruitingThis study aims to understand how well current treatments work for advanced bladder cancer in everyday medical practice. Researchers will review existing health records of 3,000 U.S. patients who started treatment after April 2023. The study will track how long treatments keep th…
Matched conditions: UROTHELIAL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC